Home » News » Awards & Advancement » Garland joins Exelixis

Garland joins Exelixis

Tuesday, October 25, 2011

Exelixis has named J. Scott Garland as executive vice president and chief commercial officer. As the company’s chief commercial officer, Gardland will oversee the commercial functions of marketing, sales and commercial operations, and collaborate closely with Exelixis’ development and manufacturing teams to provide commercial perspective for cabozantinib development efforts across multiple oncology indications.

Garland comes to Exelixis from Genentech, where he served as vice president of its Avastin franchise. Prior to that position, he served as vice president, hematology marketing and sales, overseeing the Rituxan franchise and as a director on the Tarceva franchise.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!